These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26881712)

  • 1. Revisiting Non-Cancer Drugs for Cancer Therapy.
    Yang EJ; Wu C; Liu Y; Lv J; Sup Shim J
    Curr Top Med Chem; 2016; 16(19):2144-55. PubMed ID: 26881712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in drug repositioning for the discovery of new anticancer drugs.
    Shim JS; Liu JO
    Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth.
    Yadav V; Talwar P
    Biomed Pharmacother; 2019 Mar; 111():934-946. PubMed ID: 30841473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
    Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
    Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing in Anticancer Reagent Development.
    Chen PC; Liu X; Lin Y
    Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.
    Viola-Rhenals M; Patel KR; Jaimes-Santamaria L; Wu G; Liu J; Dou QP
    Curr Med Chem; 2018 Feb; 25(4):506-524. PubMed ID: 29065820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
    Iwata M; Hirose L; Kohara H; Liao J; Sawada R; Akiyoshi S; Tani K; Yamanishi Y
    J Med Chem; 2018 Nov; 61(21):9583-9595. PubMed ID: 30371064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
    Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
    Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting new indications for approved drugs using a proteochemometric method.
    Dakshanamurthy S; Issa NT; Assefnia S; Seshasayee A; Peters OJ; Madhavan S; Uren A; Brown ML; Byers SW
    J Med Chem; 2012 Aug; 55(15):6832-48. PubMed ID: 22780961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel role of pyrvinium in cancer therapy.
    Momtazi-Borojeni AA; Abdollahi E; Ghasemi F; Caraglia M; Sahebkar A
    J Cell Physiol; 2018 Apr; 233(4):2871-2881. PubMed ID: 28500633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
    Chen H; Wu J; Gao Y; Chen H; Zhou J
    Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
    Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
    Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor deconstruction as a tool for advanced drug screening and repositioning.
    Naik RR; Luo T; Kohandel M; Bapat SA
    Pharmacol Res; 2016 Sep; 111():815-819. PubMed ID: 27431330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
    Skrott Z; Mistrik M; Andersen KK; Friis S; Majera D; Gursky J; Ozdian T; Bartkova J; Turi Z; Moudry P; Kraus M; Michalova M; Vaclavkova J; Dzubak P; Vrobel I; Pouckova P; Sedlacek J; Miklovicova A; Kutt A; Li J; Mattova J; Driessen C; Dou QP; Olsen J; Hajduch M; Cvek B; Deshaies RJ; Bartek J
    Nature; 2017 Dec; 552(7684):194-199. PubMed ID: 29211715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
    Sohraby F; Aryapour H
    Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.